Report: FDA Mandates 50% Efficacy for COVID-19 Vaccines
Vaccine candidates must be at least 50 percent more effective than a placebo to be considered for Food and Drug [...]
Pandemic Puts Pressure on FDA on RWD
The COVID-19 pandemic has put increased pressure on the Food and Drug Administration's real-world data initiatives. According to a Pink [...]
Mental Care Utilization Poised to be Key Driver of Health Spending Next Year
PwC in a new analysis suggests utilization of mental care services will be a key driver of health spending next [...]
Report on PBM Market Forecasts 7% CAGR Between 2019-2025
A new report from Arizton forecasts a compound annual growth rate of 7 percent for the pharmacy benefit management market [...]
Webinar to Highlight Marketplace Trends, COVID-19’s Impact
The Academy of Managed Care Pharmacy (AMCP) is set to host a July 9 webinar on trends in the health [...]
Reminder: ICER Accepting Comments on Annual Unsupported Price Increase Assessment
The Institute for Clinical and Economic Review (ICER) is accepting public input on the target drugs for this year's Unsupported [...]
PhRMA Foundation Extends Deadline on Applications for Value Assessment Awards
The PhRMA Foundation announced an extended application deadline for the foundation's 2020 Value Assessment Awards. Applications are due July 15. [...]
Gilead Sets Price for Remdesivir
Gilead announced it would charge between $2,340 and $3,120 for a 5-day course of its COVID-19 drug remdesivir, BioPharma Dive [...]
ICER President: Remdesivir Price was ‘Responsible’ Decisions
The Institute for Clinical and Economic Review's president, Steven Pearson, says Gilead's decision to price its COVID-19 treatment remdesivir at [...]
DistillerSR Week 2020 Recap Reel
The Evidence Partners posted a quick highlight reel of DistillerSR Week 2020, its first-ever virtual user conference. Click here to [...]
PRMA’s Nathan White: Why Understanding Payer Archetypes is Key to U.S. Market Access
Via PRMA Consulting Until recently, pharma’s biggest market access challenge in the U.S. has been learning to navigate "known unknowns." [...]
Oncologists Grapple with Supply Shortages Amid Pandemic, Survey Finds
A new survey found that one of oncologists' biggest concerns amid the COVID-19 pandemic is supply shortages, Specialty Pharmacy Continuum [...]
Pricing a COVID-19 Vaccine
A recent episode of NPR's INDICATOR offers a look at the issue of pricing a vaccine for COVID-19. The episode [...]
How is COVID-19 Impacting RWD-Based Initiatives in Oncology?
A recent OncLive article looks at how the COVID-19 pandemic is shaping real-world data initiatives in the oncology landscape. The [...]
Proposed Medicaid Changes Aim to Foster Innovative Contracts
The Centers for Medicare and Medicaid Services (CMS) is hoping to encourage greater use of innovative contracting models in a [...]
Cytel Outlines Use of Bayesian Methodologies
A new white paper from Cytel outlines how its statisticians have used Bayesian methodologies in the search for effective COVID-19 [...]
IQVIA Offering On-Demand Webinar on RWE
IQVIA is offering on-demand access to its recent web event on real-world evidence. The webinar was hosted in partnership with [...]
CSRxP’s Aronson: Pharma Must Halt Summer Price Hikes
The Campaign for Sustainable Rx Pricing (CSRxP) is calling on the pharmaceutical industry to halt summer price hikes as the [...]
Article Highlights Causes, Potential Solutions for High Drug Prices
While there are "no easy solutions" to high drug prices, there are a number of steps that could help wrangle [...]
ISPOR Plans Educational Webinar for Members
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar aimed at helping members bolster [...]
ICER to Assess Roxadustat for Treatment Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) announced plans to assess FibroGen's roxadustat for the treatment of anemia in [...]
ISPOR Offers Short Courses on Medical Devices, Payment Models
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering short courses on medical devices and different payment models [...]
PBMs Report Ease in Demand for Hydroxychloroquine
Pharmacy benefit managers last month reported an easing of demand for the antimalarial drug hydroxychloroquine following a rapid surge spurred [...]
Valid Insight Report Explores Insights from Roundtable on Payer Engagement
A new report from Valid Insight explores key insights generated from a roundtable discussion on payer engagement. The white paper, [...]
Podcast Highlights ‘Buy and Bill’ Model in Oncology
Memorial Sloan Kettering Cancer Center's Dr. Aaron Mitchell in the latest Relentless Health Value podcast discusses the "buy and bill" [...]